RE:GUD and INFLATIONStockoman1 wrote: With a stagnant stock price, and paying no dividend, inflation has eroded the value of Gud stock held in your investment account.........just sayin...
It is true.
And the same could have been said about Paladin Labs throughout their early years.
What your initial investment in Paladin gave you was a CAGR of 27% over 19 years of patient business development. Addiitional money invested in later years would have returned much higher CAGR.
It's also important to understand that Knight may not be acquired in the same manner that Paladin was acquired - but - the final growth over 19 years at Knight should be much more impressive.
Knight's free cash generation and geographic reach is expected to outpace anything Paladin had. Each additional ROW drug that comes to market will have a revenue multiplier effect and any new geographies will also add to the effect.
Looking forward to seeing how EXELON adds to this in the early days of testing our ROW capabilities.
But to your point - have to really understand what you're buying here and if this is what you want to participate in.
Know your limits - play within them !!!!! : )